In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Torrent Pharmaceuticals Ltd.

www.torrentpharma.com

Latest From Torrent Pharmaceuticals Ltd.

Torrent Charts Gains From Unichem Acquisition, More In Store

Torrent Pharma has made “substantial progress” with the integration of the acquired Unichem business, turning around key brands and building momentum in field force productivity. Rationalization efforts are expected to drive additional cost savings going forward.

India Commercial

Here’s What Competition Looks Like In India’s Humira Biosimilars Market

Competition may be just readying to jump in and gnaw into Humira’s share in Europe later this year, but the Indian market for biosimilar adalimumab already has more than half a dozen players, with distinct pricing characteristics. Scrip takes a peek into the competitive market.

India Commercial

Curatio Nets $20m Investment As Dermatology Stays On PE Menu

Private equity group ChrysCapital is investing $20m in the Indian firm Curatio Healthcare, underscoring the continuing interest in the niche dermatology space that generally sees healthy margins.

Commercial Strategy

Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine

Partner Therapeutics takes on Sanofi's immunostimulant. Novartis transitions struggling Arzerra for compassionate use only outside the US, with compensation to Genmab, while Shire licenses I.V. immunoglobulin candidate from AB Biosciences.

Deals M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Torrent Pharmaceuticals Ltd.
  • Senior Management
  • Sudhir Mehta, Chmn.
  • Contact Info
  • Torrent Pharmaceuticals Ltd.
    Phone: (91) 79 2658 5090
    Torrent House, Off. Ashram Rd.
    Ahmedabad, 380 009
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register